Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Viva Gold Reports Strong Initial Assay Results for its Fall 2024 Drill Program (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Psychemedics Corp PMDI

Healthcare Medical Care
Psychemedics Corporation is a hair drug testing company. The Company provides testing services for the detection of drugs of abuse through the analysis of hair samples. Its testing methods utilize a patented technology that digests the hair and releases drugs trapped in the hair without destroying the drugs. The Company customizes its enzyme immunoassay (EIA) procedures to drug test hair... see more

Recent & Breaking News (OTCPK:PMDI)

Psychemedics Corporation Announces Reverse and Forward Stock Split

GlobeNewswire December 2, 2024

Psychemedics Corporation Reminds Stockholders to Cast Their Votes for Upcoming Annual Meeting of Stockholders

GlobeNewswire November 18, 2024

Psychemedics Corporation Reports Third Quarter 2024 Financial Results

GlobeNewswire November 12, 2024

Psychemedics Releases First-Ever Education Insights Report: Uncovering Drug Trends in Educational Institutions Through Hair Testing

GlobeNewswire September 26, 2024

Psychemedics Corporation Launches New Ketamine Hair Testing Service

GlobeNewswire August 29, 2024

Psychemedics Corporation Reports Second Quarter 2024 Financial Results

GlobeNewswire August 13, 2024

Psychemedics Corporation's Board of Directors Approves Plan to Terminate Registration of Its Common Stock

GlobeNewswire August 12, 2024

Psychemedics Unveils Inaugural Insights Report: Revealing Drug Trends Through Hair Testing

GlobeNewswire June 21, 2024

Psychemedics Corporation Reports First Quarter 2024 Financial Results

GlobeNewswire May 14, 2024

Psychemedics Corporation Reports 2023 Financial Results

GlobeNewswire March 28, 2024

Psychemedics Recognized as a Top 10 Employee Health Testing Services Provider

GlobeNewswire March 21, 2024

Psychemedics Corporation Announces Relocation of Headquarters to Dallas, Texas

GlobeNewswire January 2, 2024

Psychemedics Corporation Appoints Daniella Mehalik as VP - Finance

GlobeNewswire November 27, 2023

Psychemedics Corporation Reports Third Quarter 2023 Financial Results

GlobeNewswire November 9, 2023

Unveiling the Future of Drug Testing: Psychemedics Introduces Advanced 5-Panel Drug Screen

GlobeNewswire October 27, 2023

Psychemedics Corporation Appoints Shannon Shoemaker as Chief Revenue Officer

GlobeNewswire September 21, 2023

Psychemedics Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire August 18, 2023

Psychemedics Corporation Reports Second Quarter 2023 Financial Results

GlobeNewswire August 11, 2023

Psychemedics Corporation Announces CEO Succession Plan

GlobeNewswire July 12, 2023

Psychemedics Corporation Reports First Quarter 2023 Financial Results and Declares Cash Dividend

GlobeNewswire May 9, 2023